hotspot -WSS

hotspot

author：fashion 2025-09-27 23:53:31 - browse：143

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Congress: Prevent baby formula shortages by passing a new bill

WSS

Louisiana bill approved classifying abortion pills as controlled substances

Stroke rates rising, especially in working

Peter Marks talks Operation Warp Speed for Rare Diseases

Researchers CRISPR chickens in bid to protect them from bird flu

Peter Marks talks Operation Warp Speed for Rare Diseases

Medical students need to learn the potent medicine of empathy

hotspot

hotspot

entertainment

23andMe had bad news about my health. I wish a person had delivered it

There’s no way to know how good AI health technologies are

Wildfire smoke exposes gaps in outdoor worker protections

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Apple is now the first public company to be valued at $3 trillion

Lawsuit challenges CMS nursing home minimum staffing rule

Supreme Court strikes down use of affirmative action

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Virginia high school admissions case could be legal follow

A fraught question for the kids of Alzheimer’s: Is it coming for us?

explore

Guardant Health colon cancer test endorsed by FDA advisory panel

Decentralized clinical trials need collaboration to achieve wider use

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Readout LOUD podcast: Merger Mondays, Ozempic panic

Cancer cells are shown to suck energy source from immune cells

What's changing in Medicare's open enrollment this year?

explore

leisure time

leisure time

explore